Company news
Tectonic Therapeutic, Inc. news in 2021
Tectonic Therapeutic, Inc.'s news releases, calls and decks from 2021, newest first.
AVROBIO Presents Clinician Experience with FAB-GT Clinical Trial and Updated Safety Data for Investigational Gene Therapies in Fabry Disease and Gaucher Disease Type 1
November 23, 2021
AVROBIO to Present Clinical and Preclinical Data at the 14th ICIEM Conference
November 7, 2021
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 4, 2021
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome
November 2, 2021
AVROBIO Announces the Appointment of Essra Ridha, M.D., MRCP, FFPM, as Chief Medical Officer
October 25, 2021
AVROBIO to Present New Clinical and Preclinical Data Across Multiple Programs at the ESGCT 28th Annual Congress
October 5, 2021